This could reflect epigenetic silencing of CDKN2A–the gene encoding p16–in the distinct precursors of aSCLC, in line with the reported CDKN2A promoter methylation in carcinoids/NETs (45), which, as we discuss next, may represent putative progenitors of aSCLC. This evidence concerns the gene CDKN2A and carcinoid tumor.